Kedrion SpA (KEDRIM) EUR410m 144A/Reg S sr sec notes due 05/15/26 (5y). NC2 (MWC B+50bp), then at 101.688, 100.844, 100. B1/B (stable/positive). Equity claw: 3y 40% at 102.275. Via BNP/JPM (B&D) jt glocos/CA/IMI/Mediobanca/Natixis/UniCredit jt books. No reg rights. List Dublin. NY law. Settles 05/06 (T+4). Reg S ISIN: XS233950017. IPT: high 3s. Px talk: 3.50% area (+/- 0.125%). Final px: 3.375%.
Priced: 3.375% at 100. +393bp vs OBL 0% 04/10/26.
Did investor call at 11am 04/26. 1x1 calls 04/26-28. Books closed at 2pm UOP: repay debt (EUR238m bank debt, tender for its EUR150m notes due 2022), fund cash on the B/S, GCP. Biz: global biopharmaceutical group specializing in the collection of human plasma and the development, production and distribution of plasma-derived products. HQ: Barga, Lucca, Italy.
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.